CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Immunoprecise Antibodies Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Immunoprecise Antibodies Ltd
3204-4464 Markham St
Phone: (250) 483-0308p:250 483-0308 VICTORIA, BC  V8Z 7X8  Canada Ticker: IPAIPA
Business Summary
ImmunoPrecise Antibodies Ltd. is a Canada-based biotherapeutic research and technology company. It leverages systems biology, multiomics modelling and artificial intelligence systems to support its technologies in bioplatform-based antibody discovery. Its services include highly specialized, full-continuum therapeutic biologics discovery, development, and out-licensing to support its business partners to discover and develop novel biologics. It utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases. It offers services, such as immunogen design and manufacturing, B cell sorting incorporating its function-first B cell screening and sequencing, and the production and screening of custom, immune, and naive phage display libraries. It also operates LSA instrument platform, which is a provider of high-throughput large and small molecule screening and characterization solutions.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
1/31/20244/30/2023YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
2836 Biological products, except diagnostic substances
8734 Testing laboratories
7374 Computer processing and data preparation and processing services

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board MitchLevine 63 10/3/2023 10/3/2023
President, Chief Executive Officer, Director Jennifer L.Bath 5/1/2018 2/21/2018
Interim Chief Financial Officer KristinTaylor 9/29/2023 9/29/2023
7 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Bioclue BV Fabrieksstraat, 7 Hamont-Achel Belgium
Biokey BV Fabrieksstraat, 7 Hamont-Achel Belgium
Biostrand BV Fabrieksstraat, 7 Hamont-Achel Belgium
3 additional Subsidiary records available in full report.

Business Names
Business Name
0496106 BC Ltd
Bioclue BV
Biokey BV
10 additional Business Names available in full report.

General Information
Number of Employees: 102 (As of 4/30/2023)
Outstanding Shares: 26,315,260 (As of 1/31/2024)
Stock Exchange: CVE
Fax Number: (250) 483-0309


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024